Cited by 22Dementia and Cognitive Impairment ResearchArtificial Intelligence in HealthcareAlzheimer's disease research and treatments

Sociodemographic data and APOE-ε4 augmentation for MRI-based detection of amnestic mild cognitive impairment using deep learning systems

Open access
Pelka, Obioma, Friedrich, Christoph M., Nensa, Felix, Mönninghoff, Christoph, Bloch, Louise, Jöckel, Karl-Heinz, Schramm, Sara, Sanchez Hoffmann, Sarah +4 more·2020·PLoS ONE

Abstract

Detection and diagnosis of early and subclinical stages of Alzheimer's Disease (AD) play an essential role in the implementation of intervention and prevention strategies. Neuroimaging techniques predominantly provide insight into anatomic structure changes associated with AD. Deep learning methods have been extensively applied towards creating and evaluating models capable of differentiating between cognitively unimpaired, patients with Mild Cognitive Impairment (MCI) and AD dementia. Several published approaches apply information fusion techniques, providing ways of combining several input sources in the medical domain, which contributes to knowledge of broader and enriched quality. The aim of this paper is to fuse sociodemographic data such as age, marital status, education and gender, and genetic data (presence of an apolipoprotein E (APOE)-ε4 allele) with Magnetic Resonance Imaging (MRI) scans. This enables enriched multi-modal features, that adequately represent the MRI scan visually and is adopted for creating and modeling classification systems capable of detecting amnestic MCI (aMCI). To fully utilize the potential of deep convolutional neural networks, two extra color layers denoting contrast intensified and blurred image adaptations are virtually augmented to each MRI scan, completing the Red-Green-Blue (RGB) color channels. Deep convolutional activation features (DeCAF) are extracted from the average pooling layer of the deep learning system Inception_v3. These features from the fused MRI scans are used as visual representation for the Long Short-Term Memory (LSTM) based Recurrent Neural Network (RNN) classification model. The proposed approach is evaluated on a sub-study containing 120 participants (aMCI = 61 and cognitively unimpaired = 59) of the Heinz Nixdorf Recall (HNR) Study with a baseline model accuracy of 76%. Further evaluation was conducted on the ADNI Phase 1 dataset with 624 participants (aMCI = 397 and cognitively unimpaired = 227) with a baseline model accuracy of 66.27%. Experimental results show that the proposed approach achieves 90% accuracy and 0.90 F1-Score at classification of aMCI vs. cognitively unimpaired participants on the HNR Study dataset, and 77% accuracy and 0.83 F1-Score on the ADNI dataset.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pone.0236868

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 5

  1. [7]Valavanis L, Stathopoulos S, Kalamboukis T. IPL at CLEF 2016 Medical Task. In: Working Notes of CLEF 2016—Conference and Labs of the Evaluation forum, Évora, Portugal, 5-8 September, 2016.; 2016. p. 413–420. Available from: http://ceur-ws.org/Vol-1609/16090413.pdf.
  2. [27]de Herrera AGS, Müller H, Bromuri S. Overview of the ImageCLEF 2015 Medical Classification Task. In: Working Notes of CLEF 2015—Conference and Labs of the Evaluation forum, Toulouse, France, September 8-11, 2015. vol. 1391; 2015. Available from: http://ceur-ws.org/Vol-1391/172-CR.pdf.
  3. [52]Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, et al Mild cognitive impairment—Beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment. Journal of internal medicine. 2004; 256: 240– 6. 10.1111/j.1365-2796.2004.01380.x 15324367 · DOI · Paper page
  4. [65]Huang G, Liu Z, Van Der Maaten L, Weinberger KQ. Densely Connected Convolutional Networks. In: Proceedings of the IEEE Conference on Computer Vision and Pattern Recognition, CVPR, Honolulu, USA, July 22-25, 2017; 2017. p. 2261–2269.
  5. [68]Ben Abacha A, Hasan SA, Datla VV, Liu J, Demner-Fushman D, Müller H. VQA-Med: Overview of the Medical Visual Question Answering Task at ImageCLEF 2019. In: Working Notes of CLEF 2019—Conference and Labs of the Evaluation Forum, Lugano, Switzerland, September 9-12, 2019.; 2019. Available from: http://ceur-ws.org/Vol-2380/paper_272.pdf.

Cited by

Sorted by citations

Authors
Pelka, O., Friedrich, C. M., Nensa, F., Mönninghoff, C., Bloch, L., Jöckel, K.-H., Schramm, S., Sanchez Hoffmann, S., Winkler, A., Weimar, C., Jokisch, M., & Initiative, F. T. A. D. N.
Affiliations
  • Dortmund University of Applied Sciences and Arts (DE)
  • Essen University Hospital (DE)
  • Clemenshospital Münster (DE)
  • Institut für Medizinische Informatik, Biometrie und Epidemiologie (DE)
Corresponding author
Friedrich, Christoph M.
Venue
PLoS ONE
Published
2020-09-25
Volume
15
Issue
9
Pages
e0236868
ISSN
1932-6203 (ISSN-L)
OpenAlex
W3088432570
Cited by
22
References
72
Citations by year
2026: 4 · 2025: 3 · 2024: 6 · 2023: 2 · 2022: 4 · 2021: 3
FWCI
1.64
Type
journal article
Language
en
Open access
Locations
  • PLoS ONE (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • U.S. Department of Defense (U01 AG024904, W81XWH, W81XWH-12-2-, W81XWH1220012, AG024904)
  • Foundation for the National Institutes of Health (W81XWH-12-2-0012, U01AG024904, Grant U01 AG024904, AG024904)
  • Alzheimer's Association (U01 AG024904, W81XWH-12-2-0012)
  • Bristol-Myers Squibb (U01 AG024904, AG024904, W81XWH-12-2-0012)
  • Eli Lilly and Company (U01 AG024904, AG024904, W81XWH-12-2-0012)
  • Pfizer (AG024904, W81XWH-12-2-0012, U01 AG024904)
  • Biogen (W81XWH-12-2-0012, U01 AG024904, AG024904)
  • University of Southern California (W81XWH-12-2-0012, U01 AG024904)
  • Celgene
  • F. Hoffmann-La Roche (W81XWH-12-2-0012, AG024904, U01 AG024904)
  • Meso Scale Diagnostics (U01 AG024904, AG024904, W81XWH-12-2-0012)
  • Alzheimer's Disease Neuroimaging Initiative (W81XWH-12-2–0012, U01AG024904, AG024904, W81XWH-12-2-, Department of Defense award number W81XWH-12-2-0012)
  • BioClinica (U01 AG024904, W81XWH-12-2-0012, AG024904)
  • Novartis Pharmaceuticals Corporation (W81XWH-12-2-0012, U01 AG024904, AG024904)
  • Northern California Institute for Research and Education (U01 AG024904, W81XWH-12-2-0012)
  • Kulturstiftung Essen
  • Ministerium für Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen
  • ResMed
  • European Commission
  • Deutsche Forschungsgemeinschaft (JO-170/8-1, SI 236/8–1, 236/8-1, ER 155/6-1;6-2, HO 3314/2-1, ER 155/6-1, EI 969/2-3, INST 58219/32-1, HO 3314/2-1;2-2;2-3;4-3, PE 2309/2-1, KN885/3-1, SI 236/8-1;9-1;10-1)
  • Volkswagen Foundation
  • Bundesministerium für Bildung und Forschung (01EG0401, 01ER1001D, 01GS0820_WB2-C, 01GI0860, 01GI0856, 01GI0205)
  • Deutsche Gesetzliche Unfallversicherung (FF-FP295, FP 295)
  • Eisai (W81XWH-12-2-0012, U01 AG024904, AG024904)
  • Servier (AG024904, W81XWH-12-2-0012, U01 AG024904)
  • H. Lundbeck A/S (U01 AG024904, AG024904, W81XWH-12-2-0012)
  • IXICO (AG024904, W81XWH-12-2-0012, U01 AG024904)
  • Heinz Nixdorf Stiftung (SI 236/8-1, ER 155/6-1)
  • National Institutes of Health (3u01ag024904-10s2, W81XWH, W81XWH-12-2-0012, U01-AG024904, Grant U01 AG024904, AG024904)
  • Genentech (W81XWH-12-2-0012, AG024904, U01 AG024904)
  • Canadian Institutes of Health Research (U01 AG024904, W81XWH-12-2-0012)
  • National Institute on Aging (U01-AG-024904, W81XWH-12-2–0012, AG 024904)
  • National Institute of Biomedical Imaging and Bioengineering (W81XWH-12-2-0012, U01 AG024904, AG024904)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Health Sciences › Health Professions › Health Information Management › Artificial Intelligence in Healthcare
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
Keywords
amnestic mild cognitive impairment, Alzheimer's disease, APOE ε4, magnetic resonance imaging, multimodal fusion, convolutional neural networks, InceptionV3, LSTM, early diagnosis, Heinz Nixdorf Recall Study, ADNI
MeSH terms
Deep Learning, Aged, Aged, 80 and over, Apolipoproteins E, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Socioeconomic Factors, Disease Progression, Neuroimaging, Cognitive Dysfunction, Datasets as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review